Answers are grounded in this paper and cite their sources.
This review article analyses current understanding of the role of the gut microbiome in the development of cardiovascular diseases. The gut microbiome is considered a complex environmental system involved in the regulation of metabolic, immune and inflammatory pathways that are directly relevant to cardiovascular function. Disorders in the composition and functional activity of the microbiome (dysbiosis) are associated with changes in the production of bacterial metabolites that can affect lipid metabolism, vascular tone, haemostasis and systemic inflammation. Special attention is given to the microbiome as a dynamic metabolic organ that modulates risks via the “gut-heart” axis. The article presents a detailed review of the role of important microbial metabolites, including trimethylamine N-oxide, short-chain fatty acids, and bile acid metabolites, in the pathogenesis of atherosclerosis and atherothrombosis. It is demonstrated that increased levels of trimethylamine N-oxide are associated with endothelial dysfunction, thrombocyte activation, and an increased risk of thrombotic complications, while a deficiency of short-chain fatty acids in dysbiosis contributes to an enhanced inflammatory response and disorders of vascular homeostasis. A special focus is on the relationship between the gut microbiome and bile acid metabolism and lipid metabolism regulation. The effects of new metabolites, such as phenylacetylglutamine, on adrenergic signaling and thrombus formation were investigated. It is observed that the combination of changes caused by dysbiosis constitutes a pathophysiological process involving chronic low-grade systemic inflammation, endothelial dysfunction, and increased platelet activity, thereby creating conditions conducive to the development of atherosclerosis and associated clinical complications, particularly myocardial infarction and ischemic stroke. Effects on the microbiome are a perspective area for prevention and treatment of cardiovascular diseases, therefore further researches are needed to confirm the cause-and-effect relationships.
No takes yet. Share an insight, caveat, or question.
Chmyr et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: